Send a Tweet
Most Popular Choices
Share on Facebook 10 Share on Twitter Printer Friendly Page More Sharing
OpEdNews Op Eds    H4'ed 12/3/19

We cannot end AIDS without combating antimicrobial resistance

By       (Page 1 of 1 pages) (# of views)   No comments
Author 91838
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (1 fan)
Shobha Shukla CNS
Dr Haileyesus Getahun, Director of Global Coordination and Partnership on Antimicrobial Resistance, World Health Organization (WHO)
Dr Haileyesus Getahun, Director of Global Coordination and Partnership on Antimicrobial Resistance, World Health Organization (WHO)
(Image by CNS (Citizen News Service citizen-news.org))
  Details   DMCA

With just 133 months left to end AIDS, this year's World AIDS Day underlines the urgency to step up the fight against the epidemic. Despite unprecedented progress made in scaling up HIV prevention, treatment, care and support, we are not yet on track to end AIDS by 2030. One of the major threats lurking to reverse these gains made in combating AIDS is antimicrobial resistance (AMR).


Antimicrobial resistance (AMR) develops when microorganisms - like bacteria, virus, fungi, and other parasites - undergo genetic changes, making them resistant to the medicines that they responded to earlier. This is an evolutionary change, but the process can be accelerated due to overuse or misuse of drugs in humans, animals and food production. It can also be exacerbated by lack of water and sanitation and simple prevention measures such as infection control and vaccination.

The 20th International Conference on AIDS and STIs in Africa (ICASA 2019) taking place in Kigali, Rwanda, is yet another opportunity we cannot afford to miss to focus on tackling AMR in the context of HIV, sexually transmitted infections (STIs), tuberculosis (TB), and other HIV-associated and non-associated conditions.

"Antimicrobial resistance and drug resistant infections pose the greatest threat in achieving the Sustainable Development Goals including our efforts on universal health coverage and the elimination of AIDS as a public health threat by 2030" said Dr Haileyesus Getahun, who is Director of Global Coordination and Partnership on Antimicrobial Resistance at the World Health Organization (WHO).

He added that, "There are a lot of untapped opportunities of synergy between disease-specific programmes, like HIV and TB, and the response against antimicrobial resistance for better outcomes to patients, their families and communities, particularly in resource limited settings."

Maximizing the application of the public health approach and infrastructure of TB and HIV programmes, particularly on laboratory strengthening, integrated and standardized surveillance, ensuring access to quality and affordable drugs and infection prevention and control measures will be critical to advance the response against antimicrobial resistance, and it will be mutually beneficial for both-the TB and HIV, and the AMR communities, he said.

Dr Ishwar Gilada, Governing Council member of International AIDS Society (IAS) pointed out that patients who stay on antiretroviral therapy (ART) for longer periods tend to develop resistance to the drugs. He said to CNS (Citizen News Service, www.citizen-news.org), "In India, almost 5% of new HIV-infected people are found to be already resistant. So, like in the United States, the ART centres in India and other HIV high-burden nations in Africa and other regions, should perform the drug-resistance tests." He appealed that the Indian pharmaceutical generic companies should also focus on making genetic viral load and resistance test kits, which will lower the costs substantially, like it has been done for ART medicines. Then India and African countries can do resistance test either before starting the ART or at the instance of first virological failure.

Despite being preventable and curable, TB continues to remain the most-common opportunistic infection, and the biggest cause of death among people living with HIV. 250,000 people with HIV died due to TB in 2018. Annual drug-resistant TB cases have hovered around half a million since past few years globally. Anti-TB drug resistance is not only impacting the fight against TB, but also undermining efforts to eliminate HIV by 2030.

"The emergence of resistance to antimicrobials and the transmission of drug resistant infections and diseases are major concerns of global health which threaten animal and human health, food supply and food safety worldwide", said Dr Getahun.

He added that drug resistant pathogens can circulate between humans, animals and the environment. Misuse and overuse of antimicrobials in animals, humans or plants is a major factor driving the emergence and development of antimicrobial resistance.

Antimicrobial resistance is a complex problem that requires a comprehensive response by way of a 'One Health' approach, including human, animal, food safety and security as well as the environment. Dr Getahun said that efforts to combat antimicrobial resistance across the One Health spectrum should embrace public health at the centre and there is no better opportunity than drawing lessons from HIV and TB programmes to enhance programmatic scale up to tackle antimicrobial resistance including through universal health coverage.

Heads of 193 countries have committed to deliver on the promise of Universal Health Coverage (UHC) along with other SDGs. In the lead up to World UHC Day (12 December), let us reinforce that combating AMR is a critical cog-in-the-wheel for sustainable development, including eliminating HIV as a public health problem, where no one is left behind. While the call for accelerating research and development for new treatments is rightly getting more attention, we should make sure that we do not lose the efficacy of existing drugs to antimicrobial resistance.

Shobha Shukla CNS (Citizen News Service)
(Shobha Shukla is the Managing Editor of CNS (Citizen News Service), and coordinator of Asia Pacific Media Network to end TB & tobacco and prevent NCDs (APCAT Media Network). Follow her on Twitter @shobha1shukla or visit www.citizen-news.org)

- Shared under Creative Commons (CC)

 

Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: www.citizen-news.org or @cns_health or www.facebook.com/cns.page
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Progress made but work remains on firewalling health policy from tobacco industry

World Health Day: No substitute to healthy mind

Nepal leading tobacco control in South Asia: Will it spiral domino effect on other nations?

Comments Image Post Article Comment and Rate This Article

These discussions are not moderated. We rely on users to police themselves, and flag inappropriate comments and behavior. In accordance with our Guidelines and Policies, we reserve the right to remove any post at any time for any reason, and will restrict access of registered users who repeatedly violate our terms.

  • OpEdNews welcomes lively, CIVIL discourse. Personal attacks and/or hate speech are not tolerated and may result in banning.
  • Comments should relate to the content above. Irrelevant, off-topic comments are a distraction, and will be removed.
  • By submitting this comment, you agree to all OpEdNews rules, guidelines and policies.
          

Comment Here:   


You can enter 2000 characters. To remove limit, please click here.

Please login or register. Afterwards, your comment will be published.
 

Username
Password

Forgot your password? Click here and we will send an email to the address you used when you registered.
First Name
Last Name

I am at least 16 years of age
(make sure username & password are filled in. Note that username must be an email address.)

No comments  Post Comment

 
Want to post your own comment on this Article? Post Comment